金陵藥業(000919.SZ):金陵天頤擬不超1.5億元競拍蜀山區一社會福利用地
格隆匯1月11日丨金陵藥業(000919.SZ)公佈,公司於2022年1月11日召開第八屆董事會第十六次會議審議通過了《關於參與競拍土地使用權的議案》。為滿足公司投資建設合肥金陵天頤智慧醫養項目的用地需求,董事會同意全資子公司合肥金陵天頤智慧養老服務有限公司(以下簡稱“金陵天頤”)在人民幣1.5億元範圍內參與蜀山區史河路以南、青陽路以東社會福利用地使用權的競拍,並授權金陵天頤管理層辦理本次競拍、購買等相關法律手續並簽署相關文件及辦理土地權屬證照等事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.